We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Partnership Programs to Reduce Ethnic Differences in the Risk of Cardiovascular Disease (META-HEALTH)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00101517
First Posted: January 11, 2005
Last Update Posted: September 16, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Arshed A. Quyyumi, Emory University
  Purpose
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, the study seeks to systematically characterize potential ethnic differences in obesity-related CVD by drawing upon the fields of psychology, physiology, biochemistry, nursing, and clinical medicine.

Condition
Cardiovascular Diseases Heart Diseases Obesity Metabolic Syndrome X

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Partnership Programs to Reduce Cardiovascular Disparities - Morehouse-Emory Partnership

Resource links provided by NLM:


Further study details as provided by Arshed A. Quyyumi, Emory University:

Enrollment: 4024
Study Start Date: September 2004
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 78 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
African-American and white residents in the metro Atlanta area (Cobb, DeKalb, Fulton, Gwinnett counties) aged 30-78 years
Criteria
  • African-American or White residents of the metro Atlanta area
  • aged 30-78 years
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00101517


Locations
United States, Georgia
Morehouse School of Medicine
Atlanta, Georgia, United States, 30310
Emory University School
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Gary Gibbons Morehouse School of Medicine
Principal Investigator: Arshed Quyyumi Emory University
  More Information

Responsible Party: Arshed A. Quyyumi, Principal Investigator, Emory University
ClinicalTrials.gov Identifier: NCT00101517     History of Changes
Other Study ID Numbers: IRB00024856a
U01HL079156 ( U.S. NIH Grant/Contract )
U01HL079214 ( U.S. NIH Grant/Contract )
1284 ( Other Identifier: Other )
First Submitted: January 10, 2005
First Posted: January 11, 2005
Last Update Posted: September 16, 2014
Last Verified: September 2014

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Metabolic Syndrome X
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases